MYOCARDIAL PERFUSION AFTER INTRACORONARY INFUSION OF MONONUCLEAR CELLS OF BONE MARROW OR PERIPHERAL BLOOD AFTER ACUTE MYOCARDIAL INFARCTION  by Afsharzada, Farshid et al.
A110.E1024
JACC March 9, 2010
Volume 55, issue 10A
 MYOCARDIAL ISCHEMIA AND INFARCTION 
MYOCARDIAL PERFUSION AFTER INTRACORONARY INFUSION OF MONONUCLEAR CELLS OF BONE 
MARROW OR PERIPHERAL BLOOD AFTER ACUTE MYOCARDIAL INFARCTION
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Myocardial Ischemia/Infarction: Cell-Based Therapy
Abstract Category: Myocardial Ischemia/Infarction--Basic
Presentation Number: 1103-296
Authors: Farshid Afsharzada, Robin Nijveldt, Alexander Hirsch, Pieter A van der Vleuten, Aernout M. Beek, Jan G.P. Tijssen, Jan J. Piek, Felix Zijlstra, 
Albert C. van Rossum, VU University Medical Center, Amsterdam, The Netherlands, Interuniversity Cardiology Institute of the Netherlands, Utrecht, 
The Netherlands
Background: Several experimental and clinical studies suggest that stem cell derived elements have the potential to induce therapeutic 
neoangiogenesis of ischemic tissue. We evaluated the effects of intracoronary infusion of mononuclear cells on the recovery of myocardial perfusion 
after reperfused acute myocardial infarction (AMI) in the multicenter HEBE trial.
Methods: A total of 94 patients after primary percutaneous coronary intervention (PCI) were randomly assigned to intracoronary infusion of 
mononuclear cells of bone marrow (BM, n=30), peripheral blood (PB, n=34) or standard therapy (n=30). Myocardial perfusion was assessed by 
Cardiovascular Magnetic Resonance first pass imaging at baseline and at 4 months follow-up. Semi-quantitative analysis was performed in the 
infarct core and rim, by use of the relative upslope of the signal intensity time curve (SI) and the time to 50% of the maximum myocardial upslope (T 
50%max). Analysis of covariance was used to control for baseline perfusion variables.
Results: After 4 months, the mean relative upslope in the infarct core in the BM group was 8.9±2.9% and in the PB group 10.9±5.7%, compared 
to the control group (7.8±4.6, p=0.35 and p=0.69 respectively). The mean relative upslope in the infarct rim was also comparable between the 
BM group and control (9.9±3.1 versus 8.9±3.9, p=0.31) and the PB group and control (10.5±3.7 versus 8.9±3.9, p=0.14). Furthermore, mean T 
50%max in the infarct core between the BM group and control (11.9±2.1 versus 11.6±4.0, p=0.77) and the PB group and control (12.0±2.9 versus 
11.6±4.0, p=0.72), and in the infarct rim between the BM group and control (12.1±2.3 versus 12.6±3.5, p=0.33) and the PB group and control 
(12.8±2.6 versus 12.6±3.5, p=0.89), was also comparable.
Conclusions: Intracoronary infusion of mononuclear cells of BM or PB does not enhance myocardial perfusion after reperfused AMI.
